Diabetes News

Low-carbohydrate diets centered on macronutrients from whole grains, fruit and vegetables are associated with a lower mortality risk for people with type 2 diabetes, according to study data.

People on a time-restricted intermittent fasting diet, eating only between 8:00 a.m. and 12:00 p.m. for 3 days per week, had greater improvements in glucose tolerance at 6 months than those on a restricted caloric diet, data show.

Continuous glucose monitoring has been firmly established as beneficial for helping people with diabetes understand their glucose profile, but whether these metrics translate for people without diabetes is still unclear.

Adults who improve from prediabetes to normoglycemia do not have a lower risk for death compared with those with persistent prediabetes, but lifestyle modification can help reduce mortality risk, according to study data.

Calorie-restricted diets, particularly in conjunction with an intensive lifestyle modification program, were associated with increased remission rates among patients with type 2 diabetes, according to a meta-analysis of 28 randomized trials.

Abbott has issued a voluntary medical device correction to warn users about the potential for battery swelling, overheating or fire with three of its FreeStyle Libre readers.

Recent shortages of the type 2 diabetes therapies semaglutide and tirzepatide, widely reported in the consumer press, appear to be resolving, according to manufacturers and prescribers.

A deep learning model utilized unstructured electronic health record data to identify specific patient-, physician- and system-level reasons for statin nonuse among patients with diabetes, researchers reported.

NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.

NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.